Source: Annual Congress 2004 - PG7 - Application of genomics and proteomics to pulmonary disease



Rating:

Share or cite this content

Citations should be made in the following way:
L. Rosenwasser (Denver, United States Of America). Role of pharmacogenomics in host response to treatment. Annual Congress 2004 - PG7 - Application of genomics and proteomics to pulmonary disease

Member's Comments

No comment yet.

Related content which might interest you: Role of altered immune response in CF and implication for antiinflammatory therapies Source: Research Seminar 2012 - Pulmonary inflammation in paediatric respiratory disease Year: 2012 Dysregulation of host defence peptides by environmental challenge: Can we mitigate the pathophysiology? Source: International Congress 2019 – Infections, the microbiome and host defence peptides in the development and progression of asthma Year: 2019 Oral presentation: Targeting of microRNAs can restore innate anti-viral response in asthma Source: Lung Science Conference 2014 - Lung Inflammation and Immunity Year: 2014 Role of adaptive immunity in clinical variability of active tuberculosis patients Source: Virtual Congress 2021 – Novel imaging analysis methodologies in diffuse lung diseases Year: 2021 Targeting intermittent hypoxia downstream pathways for biomarker discovery and new treatment perspectives in cutaneous melanoma Source: Eur Respir J, 53 (2) 1802444; 10.1183/13993003.02444-2018 Year: 2019 Immunology and defence mechanism of the developing lung Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-50-2, page=60 Year: 2006 Role of immune cells Source: International Congress 2015 – PG6 Cell-matrix dynamics in lung injury and repair Year: 2015 Improving the innate immune response in respiratory infections: the use of repurposed drugs Source: Virtual Congress 2020 – Antibiotic resistance: the way forward Year: 2020 Immunotherapy improves inflammatory response and lymphocyte apoptosis as a new therapeutic target in sepsis rat Source: Annual Congress 2009 - Severe sepsis and multiple organ failure Year: 2009 Targeting the arginase pathway: potential developments as new avenues for treatment Source: Annual Congress 2004 - Arginase: a novel target and marker for asthma? Year: 2004 Optimizing the target therapy development Source: ERS Research Seminar Year: 2015 Delivery of siRNA to the lungs and airways Source: Annual Congress 2005 - Selective gene knockout - the use of small interference RNA Year: 2005 The microbiome, cancer development and response to therapy Source: International Congress 2018 – Scientific Year in Review Year: 2018 Precision medicine in tuberculosis treatment – a role for pharmacogenetics? Source: International Congress 2018 – Challenges in tuberculosis care Year: 2018 Dynamics of IFN-ß responses during respiratory viral infection: insights for therapeutic strategies Source: International Congress 2019 – Mechanisms underlying respiratory infection Year: 2019 Regulation of immune response plasticity – A path to success in pulmonary diseases management Source: Annual Congress 2012 - Cell biology and inflammatory gene expression in chronic lung disease Year: 2012 ICS/LABA effects on antiviral innate immune response. An in vitro analysis. Source: International Congress 2019 – Novel targets and mechanisms in asthma Year: 2019 Host response (immune response) Source: Virtual Congress 2020 – Basic science Year: 2020